InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Diamond Stuart. Director active across 1 company, notably bioAffinity Technologies, Inc.. In total, 5 reports have been published. Split: 1 buy · 0 sell. History available since 1 January 2023. The latest transaction was filed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
DIAMOND STUART is a declarant and a Director of bioAffinity Technologies, Inc. (XNAS). The file shows 5 filings in total, and across the sampled recent filings the reported aggregate amounts are 0 for buys and 0 for sells, with dates ranging from 2022-12-02 to 2024-07-02. The modal transaction nature is Attribution.